Medidata Solutions trades as part of the application software industry and trades as part of the technology sector. The company CEO is Tarek A Sherif. Medidata Solutions Inc provides cloud-based solutions for life sciences. Its customers are pharmaceutical, biotechnology, and medical device companies, academic institutions, and contract research organizations.
Previous Intraday Trading Performance:
The MDSO stock showed a previous change of 4.36% with an open at 90.91 and a close of 94.75. It reached an intraday high of 95.18 and a low of 90.05.
The stock has a market cap of $5.9b with 62.3m shares outstanding, of which the float is 59.3m shares. Trading volume reached 2,677,128 shares compared to its average volume of 858,031 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Medidata Solutions shares returned 3.69% and in the past 30 trading days it returned 4.88%. Over three months, it changed 27.16%. In one year it has changed 16.80% and within that year its 52-week high was 98.60 and its 52-week low was 60.10. MDSO stock is 57.65% above its 52 Week Low.
Our calculations show a 200 day moving average of 76.43 and a 50 day moving average of 86.93. Currently MDSO stock is trading 23.96% above its 200 day moving average.
The last annual fiscal EPS for the company was reported at 0.84 that ended on 31st of December 2018, which according to the previous close, that is a PE of 112.80. Based on 7 analyst estimates, the consensus EPS for the next quarter is 0.11. The TTM EPS is 0.95, which comes to a TTM PE of 99.74. Historically, the PE high was 542.90 and the PE low was 73.60. If the stock reached its PE low, that would represent a price of 69.92, which is a decrease of -26.21%.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||(Reported on 04/30/2019):||0.18|
|4th||Qtr of 2018||(Reported on 02/12/2019):||0.23|
|3rd||Qtr of 2018||(Reported on 10/18/2018):||0.17|
|2nd||Qtr of 2018||(Reported on 07/24/2018):||0.27|
|1st||Qtr of 2018||(Reported on 04/19/2018):||0.17|
Base on our calculations, the intrinsic value per share is 62.07, which means it may be overvalued by -52.65%.
Indicators to Watch:
The current calculated beta is 1.28.
Based on last reported financials, the company’s return on equity is 9.48%, return on assets is 5.34%, profit margin is 8.04%, price-to-sales is 8.56 and price-to-book is 8.88.
All scores are out of six:
0 :Valuation Score
1 :Past Performance Score
6 :Financial Strength Score
4 :Future Growth Score
0 :Dividend Score
2 :Overall Score